154 related articles for article (PubMed ID: 9692307)
1. Hepatitis associated with terbinafine therapy: three case reports and a review of the literature.
Gupta AK; del Rosso JQ; Lynde CW; Brown GH; Shear NH
Clin Exp Dermatol; 1998 Mar; 23(2):64-7. PubMed ID: 9692307
[TBL] [Abstract][Full Text] [Related]
2. Terbinafine-associated hepatic injury.
van 't Wout JW; Herrmann WA; de Vries RA; Stricker BH
J Hepatol; 1994 Jul; 21(1):115-7. PubMed ID: 7963410
[TBL] [Abstract][Full Text] [Related]
3. Terbinafine-associated hepatotoxicity.
Ajit C; Suvannasankha A; Zaeri N; Munoz SJ
Am J Med Sci; 2003 May; 325(5):292-5. PubMed ID: 12792250
[TBL] [Abstract][Full Text] [Related]
4. [Hepatitis attributed to the use of terbinafine].
Boldewijn OY; Ottervanger JP; Mostart CM; Janssens AR; Calame J; Jonkers GJ
Ned Tijdschr Geneeskd; 1996 Mar; 140(12):669-72. PubMed ID: 8668241
[TBL] [Abstract][Full Text] [Related]
5. [Acute hepatitis associated with terbinafine].
Vivas S; Rodríguez M; Palacio MA; Cadenas F; Lomo J; Rodrigo L
Gastroenterol Hepatol; 1997 Nov; 20(9):456-8. PubMed ID: 9445740
[TBL] [Abstract][Full Text] [Related]
6. Terbinafine-induced acute autoimmune hepatitis in the setting of hepatitis B virus infection.
Paredes AH; Lewis JH
Ann Pharmacother; 2007 May; 41(5):880-4. PubMed ID: 17426078
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis associated with terbinafine treatment.
Lowe G; Green C; Jennings P
BMJ; 1993 Jan; 306(6872):248. PubMed ID: 8443524
[No Abstract] [Full Text] [Related]
8. Terbinafine-induced prolonged cholestasis with reduction of interlobular bile ducts.
Mallat A; Zafrani ES; Metreau JM; Dhumeaux D
Dig Dis Sci; 1997 Jul; 42(7):1486-8. PubMed ID: 9246051
[TBL] [Abstract][Full Text] [Related]
9. Clinical presentation of terbinafine-induced severe liver injury and the value of laboratory monitoring: a Critically Appraised Topic.
Kramer ON; Albrecht J
Br J Dermatol; 2017 Nov; 177(5):1279-1284. PubMed ID: 28762471
[TBL] [Abstract][Full Text] [Related]
10. [Terbinafine and cholestatic hepatitis].
Tejada García M; Llvona Hevia AM; Martín Arias L; García-Pando AC
Med Clin (Barc); 1997 Sep; 109(9):356. PubMed ID: 9379769
[No Abstract] [Full Text] [Related]
11. The role of HLA-A*33:01 in patients with cholestatic hepatitis attributed to terbinafine.
Fontana RJ; Cirulli ET; Gu J; Kleiner D; Ostrov D; Phillips E; Schutte R; Barnhart H; Chalasani N; Watkins PB; Hoofnagle JH
J Hepatol; 2018 Dec; 69(6):1317-1325. PubMed ID: 30138689
[TBL] [Abstract][Full Text] [Related]
12. Terbinafine-induced cholestatic liver disease.
Lazaros GA; Papatheodoridis GV; Delladetsima JK; Tassopoulos NC
J Hepatol; 1996 Jun; 24(6):753-6. PubMed ID: 8835752
[TBL] [Abstract][Full Text] [Related]
13. Terbinafine-induced hepatitis and pancytopenia.
Conjeevaram G; Vongthavaravat V; Sumner R; Koff RS
Dig Dis Sci; 2001 Aug; 46(8):1714-6. PubMed ID: 11508672
[No Abstract] [Full Text] [Related]
14. Cutaneous adverse effects associated with terbinafine therapy: 10 case reports and a review of the literature.
Gupta AK; Lynde CW; Lauzon GJ; Mehlmauer MA; Braddock SW; Miller CA; Del Rosso JQ; Shear NH
Br J Dermatol; 1998 Mar; 138(3):529-32. PubMed ID: 9580815
[TBL] [Abstract][Full Text] [Related]
15. Terbinafine-induced hepatic dysfunction.
Chambers WM; Millar A; Jain S; Burroughs AK
Eur J Gastroenterol Hepatol; 2001 Sep; 13(9):1115-8. PubMed ID: 11564966
[TBL] [Abstract][Full Text] [Related]
16. Generalized pustular psoriasis and hepatic dysfunction associated with oral terbinafine therapy.
Kim BS; Jang HS; Jwa SW; Jang BS; Kim MB; Oh CK; Kwon YW; Kwon KS
J Korean Med Sci; 2007 Feb; 22(1):167-9. PubMed ID: 17297275
[TBL] [Abstract][Full Text] [Related]
17. Terbinafine. An update of its use in superficial mycoses.
McClellan KJ; Wiseman LR; Markham A
Drugs; 1999 Jul; 58(1):179-202. PubMed ID: 10439936
[TBL] [Abstract][Full Text] [Related]
18. Terbinafine hepatotoxicity: case report and review of the literature.
Fernandes NF; Geller SA; Fong TL
Am J Gastroenterol; 1998 Mar; 93(3):459-60. PubMed ID: 9517658
[TBL] [Abstract][Full Text] [Related]
19. Systematic review of severe acute liver injury caused by terbinafine.
Yan J; Wang X; Chen S
Int J Clin Pharm; 2014 Aug; 36(4):679-83. PubMed ID: 24986266
[TBL] [Abstract][Full Text] [Related]
20. Terbinafine exacerbates psoriasis: case report with a literature review.
Szepietowski JC
Acta Dermatovenerol Croat; 2003; 11(1):17-21. PubMed ID: 12718791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]